Common Cold News and Research RSS Feed - Common Cold News and Research

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Cough is among the most common complaints for which patients seek medical attention. Leading cough researcher Peter V. Dicpinigaitis, M.D., Professor of Clinical Medicine at New York's Albert Einstein College of Medicine, recently conducted a new cough challenge study among adults, whose results were first presented at the European Respiratory Society International Congress in September 2014. [More]
Researchers explain why people with asthma have hard time dealing with respiratory viruses

Researchers explain why people with asthma have hard time dealing with respiratory viruses

People with asthma often have a hard time dealing with respiratory viruses such as the flu or the common cold, and researchers have struggled to explain why. [More]
Computational biologists develop program for easy diagnosis of hereditary illnesses

Computational biologists develop program for easy diagnosis of hereditary illnesses

In the case of a cough or a sore throat, the doctor can usually diagnose a common cold immediately. However, the diagnosis of hereditary illnesses like cystic fibrosis, which affects the metabolism, or Huntington's disease, which leads to cognitive decline, is much more complex. [More]
Urgent Care for Kids plans to add four new clinics throughout Texas

Urgent Care for Kids plans to add four new clinics throughout Texas

Urgent Care for Kids announced plans to enter the Austin market and add four new clinics throughout the state. The practice is slated to open two new Houston-area clinics as well as two clinics in the greater Austin area by the end of the summer. Urgent Care for Kids selected these areas by identifying key growth markets where it can respond to increased demand for high quality after-hours pediatric care. [More]
Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. [More]
GENETICS and G3: Genes|Genomes|Genetics publish special collection on genetics of immunity

GENETICS and G3: Genes|Genomes|Genetics publish special collection on genetics of immunity

Immunity is what stops you dying from a common cold or a tiny pinprick. Differences in resistance or tolerance to disease influence who catches the bug that's going around the office, or which species succumb to the deadly fungus devastating frogs around the world. [More]
MERS virus can be transmitted from camel to man

MERS virus can be transmitted from camel to man

A report published yesterday provided the first solid evidence that the Middle East Respiratory Syndrome (MERS) virus (MERS-cov) can be contracted by man through close contact with an infected camel. [More]
New discovery may shed light on how common cold triggers asthma attacks

New discovery may shed light on how common cold triggers asthma attacks

Cold season may be just behind us, but a new discovery may shed light on how this common condition triggers asthma attacks. In a new research report published in the June 2014 issue of the Journal of Leukocyte Biology, researchers show that in individuals with asthma, statins significantly reduce the in vitro inflammatory response of human monocytes to rhinovirus (RV), the cause of the common cold. [More]
Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Mathematicians at the University of York have joined forces with experimentalists at the University of Leeds to take an important step in discovering how viruses make new copies of themselves during an infection. [More]
Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Today Biogen Idec announced that Health Canada has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B. [More]
Concordia Healthcare enters into definitive agreement to acquire Donnatal

Concordia Healthcare enters into definitive agreement to acquire Donnatal

Concordia Healthcare Corp., announced today that it has entered into a definitive agreement to acquire Donnatal®, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS") and acute enterocolitis, from a privately held specialty pharmaceutical company carrying on business as Revive Pharmaceuticals ("Revive Pharmaceuticals"). [More]
FDA approves KALYDECO for people with cystic fibrosis

FDA approves KALYDECO for people with cystic fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation. [More]
Researchers discover potential treatment for viral infection that causes illnesses in children

Researchers discover potential treatment for viral infection that causes illnesses in children

Researchers have discovered a potential treatment for a viral infection that causes potentially fatal brain swelling and paralysis in children. The findings also point to possible treatments for related viruses including those that cause "common cold" symptoms. [More]
Researchers provide new insights into how common cold virus infects

Researchers provide new insights into how common cold virus infects

On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories of the Medical University of Vienna and the University of Vienna, in collaboration with two Spanish groups, have now provided new insights into this process. [More]
Duration of common pediatric respiratory infections estimated

Duration of common pediatric respiratory infections estimated

An international research team has systematically reviewed the literature to formulate up-to-date estimates of the duration of common childhood respiratory tract infections. [More]
Scientists identify genetic signature of respiratory syncytial virus

Scientists identify genetic signature of respiratory syncytial virus

Scientists have identified the genetic signature of respiratory syncytial virus, the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could allow physicians to determine the severity of the infection when symptoms first develop. The study, from a team at The Research Institute at Nationwide Children's Hospital, was published this week in PLOS Medicine. [More]
FDA approves SC formulation of Genentech's Actemra for rheumatoid arthritis

FDA approves SC formulation of Genentech's Actemra for rheumatoid arthritis

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of Actemra (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis who have used one or more disease-modifying antirheumatic drugs, such as methotrexate, that did not provide enough relief. [More]
Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

​The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation. [More]
Doctors who make eye contact seem more empathetic to patients

Doctors who make eye contact seem more empathetic to patients

Doctors who make a lot of eye contact are viewed as more likable and empathetic by patients, according to a new Northwestern Medicine- study. [More]
IBS Treatment Center opens new clinic in Santa Monica, California

IBS Treatment Center opens new clinic in Santa Monica, California

The IBS Treatment Center, which specializes in treating irritable bowel syndrome, announced the opening of a new clinic in Santa Monica, California, in late October. Conveniently located next to the UCLA Medical Center, this new branch of the clinic will provide a progressive approach to digestive health as well as easy access to treatment for patients previously without adequate care. [More]